CellCept · DIN 02242145 · 200 mg/mL · powder for oral suspension-175mL Pk
Limited Use, Reason for Use code 556 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 556 required
Write on scriptReason for Use code 556 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 556
Reason for Use code 556
For patients who are unable to swallow or tolerate solid oral dosage forms.
Coverage limit:
LU Authorization Period: Indefinite
Savings card: innoviCares lists CellCept (Ontario list dated 2026-09-10) — pays part of the brand-versus-generic difference after other coverage; free sign-up. (innovicares.ca ↗)
1 brand, same coverage
CellCept · DIN 02242145
Manufacturer: Hoffmann-La Roche Limited; listing date 2005-02-22
Health Canada: Marketed since 2002-08-27 · brand CELLCEPT · ATC L04AA06 MYCOPHENOLIC ACID · form Powder for suspension · route Oral · ingredients MYCOPHENOLATE MOFETIL 200 MG/ML · company Hoffmann-la roche limited · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242145)
Source record
DIN 02242145: CellCept
Raw flags: sec12=Y, sec3=Y
Item: 920000510; group id 939; item number 2236; lccId 00131; manufacturer id HLR
Source form: Pd for Oral Susp-175mL Pk; strength: 200mg/mL
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $358.0600; ministry $244.7025
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242145
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=65823
Interchangeable products
Mar-Mycophenolate Mofetil · DIN 02522233 · $244.7025
Shortage status: not checked (no credentials)